Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 151,844 | 192,351 | 189,854 | 201,383 | 144,531 |
| Marketable Securities | 72,236 | 60,575 | 30,356 | 90,607 | 114,710 |
| Receivables | 138,036 | 144,984 | 132,079 | 138,898 | 115,469 |
| Inventories | 153,741 | 130,316 | 122,411 | 115,494 | 105,833 |
| TOTAL | $534,071 | $545,949 | $482,645 | $555,078 | $489,600 |
| Non-Current Assets | |||||
| PPE Net | 297,345 | 295,384 | 287,999 | 288,523 | 282,746 |
| Investments And Advances | 10,996 | 0 | 9,944 | 15,163 | 15,212 |
| Other Non-Current Assets | 735,058 | 703,845 | 710,934 | 715,553 | 725,354 |
| TOTAL | $1,043,399 | $999,229 | $1,008,877 | $1,019,239 | $1,023,312 |
| Total Assets | $1,577,470 | $1,545,178 | $1,491,522 | $1,574,317 | $1,512,912 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 234 | 252 | 249 | 428 | 436 |
| Accounts payable and accrued liabilities | 157,057 | 153,268 | 131,212 | 116,697 | 93,366 |
| Accrued Expenses | N/A | N/A | N/A | 128,245 | 126,090 |
| TOTAL | $173,759 | $159,010 | $136,971 | $255,169 | $225,407 |
| Non-Current Liabilities | |||||
| Long Term Debt | 601,630 | 596,446 | 586,853 | 594,006 | 589,579 |
| Other Non-Current Liabilities | 69,783 | 62,044 | 54,352 | 52,786 | 58,505 |
| TOTAL | $671,413 | $658,490 | $641,205 | $646,792 | $648,084 |
| Total Liabilities | $845,172 | $817,500 | $778,176 | $901,961 | $873,491 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,650 | 48,081 | 48,676 | 48,902 | 48,096 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | 568,787 | 530,823 | 490,394 | 452,445 | 409,268 |
| Other shareholders' equity | -8,895 | -8,578 | -8,625 | -9,167 | -8,909 |
| TOTAL | $732,298 | $727,678 | $713,346 | $672,356 | $639,421 |
| Total Liabilities And Equity | $1,577,470 | $1,545,178 | $1,491,522 | $1,574,317 | $1,512,912 |